- Home
- YDKG vs GLMD Comparison
YDKG vs GLMD Comparison
Compare YDKG & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YDKG | GLMD |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | China | Israel |
| Employees | 17 | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8M | 4.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | YDKG | GLMD |
|---|---|---|
| Price | $0.95 | $0.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.9K | ★ 4.5M |
| Earning Date | 05-12-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.02 | $0.41 |
| 52 Week High | $3.90 | $2.34 |
Technical Indicators
Market Signals| Indicator | YDKG | GLMD |
|---|---|---|
| Relative Strength Index (RSI) | 61.11 | 49.18 |
| Support Level | $0.81 | $0.52 |
| Resistance Level | $1.04 | $0.69 |
| Average True Range (ATR) | 0.04 | 0.04 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 100.00 | 39.48 |
Price Performance
Historical ComparisonAbout YDKG Yueda Digital Holding Class A Ordinary Share
Yueda Digital Holding is a digital-economy company with a focus on the long-term accumulation of mainstream cryptocurrencies. The business activities of the company include active treasury management of mainstream digital assets, exploration of compliant, risk-managed yield opportunities, such as staking, on-chain liquidity provision, and other conservative market activities, selective investments and partnerships in Web3 infrastructure and applications, and advisory services for enterprises entering the digital-asset economy.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.